Heterozygous PINK1 p. G411S increases risk of Parkinson’s disease via a dominant-negative mechanism A Puschmann, FC Fiesel, TR Caulfield, R Hudec, M Ando, D Truban, ... Brain 140 (1), 98-117, 2017 | 137 | 2017 |
Decision making, impulsivity, and addictions: do Parkinson's disease patients jump to conclusions? A Djamshidian, SS O'Sullivan, Y Sanotsky, S Sharman, Y Matviyenko, ... Movement disorders 27 (9), 1137-1145, 2012 | 109 | 2012 |
Manganic encephalopathy due to “ephedrone” abuse Y Sanotsky, R Lesyk, L Fedoryshyn, I Komnatska, Y Matviyenko, S Fahn Movement disorders: official journal of the Movement Disorder Society 22 (9 …, 2007 | 102 | 2007 |
Parkinsonism and dystonia caused by the illicit use of ephedrone—a longitudinal study M Selikhova, L Fedoryshyn, Y Matviyenko, I Komnatska, M Kyrylchuk, ... Movement disorders: official journal of the Movement Disorder Society 23 (15 …, 2008 | 98 | 2008 |
Role for the microtubule-associated protein tau variant p. A152T in risk of α-synucleinopathies C Labbé, K Ogaki, O Lorenzo-Betancor, AI Soto-Ortolaza, RL Walton, ... Neurology 85 (19), 1680-1686, 2015 | 40 | 2015 |
Increased reflection impulsivity in patients with ephedrone‐induced P arkinsonism A Djamshidian, Y Sanotsky, Y Matviyenko, SS O'Sullivan, S Sharman, ... Addiction 108 (4), 771-779, 2013 | 29 | 2013 |
DNAJC13 p. Asn855Ser mutation screening in Parkinson's disease and pathologically confirmed Lewy body disease patients O Lorenzo‐Betancor, K Ogaki, AI Soto‐Ortolaza, C Labbé, RL Walton, ... European journal of neurology 22 (9), 1323-1325, 2015 | 27 | 2015 |
Analysis of a distinct speech disorder seen in chronic manganese toxicity following Ephedrone abuse M Selikhova, E Tripoliti, L Fedoryshyn, Y Matvienko, H Stanetska, ... Clinical Neurology and Neurosurgery 147, 71-77, 2016 | 16 | 2016 |
Frequency of mutations in PRKN, PINK1, and DJ1 in Patients With Early-Onset Parkinson Disease from neighboring countries in Central Europe ŁM Milanowski, JA Lindemann, D Hoffman-Zacharska, AI Soto-Beasley, ... Parkinsonism & related disorders 86, 48-51, 2021 | 10 | 2021 |
Drug-induced parkinsonism JH Friedman, Y Sanotsky, EC Wolter Mov Disord 32 (7), 1111, 2017 | 8 | 2017 |
Neuropathological findings in ephedrone encephalopathy Y Sanotsky, M Selikhova, L Fedoryshyn, P Kuzyk, Y Matviyenko, ... Movement Disorders 35 (10), 1858-1863, 2020 | 7 | 2020 |
Cathepsin B p. Gly284Val variant in Parkinson’s disease pathogenesis LM Milanowski, X Hou, JM Bredenberg, FC Fiesel, LT Cocker, ... International journal of molecular sciences 23 (13), 7086, 2022 | 6 | 2022 |
Reply: Heterozygous PINK1 p. G411S in rapid eye movement sleep behaviour disorder A Puschmann, FC Fiesel, TR Caulfield, R Hudec, M Ando, D Truban, ... Brain 140 (6), e33-e33, 2017 | 3 | 2017 |
PARK2, PINK1, and DJ1 in patients with early-onset Parkinson’s disease in four European countries.(2506) L Milanowski, J Lindemann, M Barcikowska, M Boczarska-Jedynak, ... Neurology 94 (15 Supplement), 2020 | 2 | 2020 |
Ephedrone-induced Parkinsonism: Clinic-neuroimaging study Y Sanotsky, M Selikhova, L Fedoryshyn, Y Matviyenko, I Komnatska, ... MOVEMENT DISORDERS 22, S107-S108, 2007 | 1 | 2007 |
The authors apologize for an error in in the author list and author affiliations, which should read as follows: Andreas Puschmann, Fabienne C. Fiesel, 3, Thomas R. Caulfield, 3 … D Koziorowski, M Rudzinska-Bar, JO Aasly, T Lynch, GD Mellick, ... Brain 140, 1-2, 2017 | | 2017 |
Heterozygous PINK1 p. G411S increases risk of Parkinson’s disease via a dominant-negative mechanism OA Ross, W Springer | | 2016 |
Heterozygous PINK1 p. G411S mutation increases risk for Parkinson's disease (PD) W Springer, A Puschmann, FC Fiesel, M Ando, TR Caulfield, K Ogaki, ... Movement Disorders 31 (Suppl. S2), S282, 2016 | | 2016 |
DNAJC13 p. Asn855Ser mutation screening in Parkinson's disease and pathologically confirmed Lewy body disease patients RJ Uitti, O Lorenzo-Betancor, K Ogaki, AI Soto-Ortolaza, C Labbe, ... | | 2015 |
Whispering disarthria-A diagnostic hint for chronic manganese poisoning MV Selikhova, E Tripolity, Y Sanotsky, Y Matvienko, H Staneska, ... Movement Disorders 29, S127-S128, 2014 | | 2014 |